Igor Puzanov - Dissemin

Language
Login

All papers authored by Igor Puzanov

This paper is made freely available by the publisher.

2023 Robert A. Beckman

ORCID

, Alvin P. Makohon-Moore

ORCID

, Igor Puzanov

ORCID

Intratumoral and Microenvironmental Heterogeneity in Patient Outcome Prediction

Download from doi.org

This paper is made freely available by the publisher.

Jason A. Chesney

ORCID

ORCID

, Georgina V. Long

ORCID

, John M. Kirkwood

ORCID

, Reinhard Dummer

ORCID

, Igor Puzanov

ORCID

, Christoph Hoeller, Thomas F. Gajewski, Ralf Gutzmer

ORCID

, Piotr Rutkowski

ORCID

, Lev Demidov, Petr Arenberger, Sang Joon Shin

ORCID

, Pier Francesco Ferrucci

ORCID

, Andrew Haydon

ORCID

and 14 other authors

Randomized, Double-Blind, Placebo-Controlled, Global Phase III Trial of Talimogene Laherparepvec Combined With Pembrolizumab for Advanced Melanoma

Download from doi.org

This paper is made freely available by the publisher.

2022 Ann W. Silk

ORCID

, Christopher A. Barker, Shailender Bhatia

ORCID

, Kathryn B. Bollin, Sunandana Chandra, Zeynep Eroglu

ORCID

, Brian R. Gastman, Kari L. Kendra, Harriet Kluger, Evan J. Lipson

ORCID

, Kathleen Madden, David M. Miller

ORCID

ORCID

, Anna C. Pavlick, Igor Puzanov

ORCID

and 6 other authors

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of nonmelanoma skin cancer

Download from doi.org

This paper is made freely available by the publisher.

Benjamin Switzer

ORCID

, Igor Puzanov

ORCID

, Joseph J. Skitzki

ORCID

ORCID

, Marc S. Ernstoff

ORCID

Managing Metastatic Melanoma in 2022: A Clinical Review

Download from doi.org

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

2016 Mahoney Km, S. Jacobus, Bhatt Rs, J. Song, I. Carvo, Cheng Sc, M. Simpson, Fay Ap, I. Puzanov

ORCID

, Michaelson Md, Atkins Mb, McDermott Df, S. Signoretti, Choueiri Tk

Phase 2 Study of Bevacizumab and Temsirolimus After VEGFR TKI in Metastatic Renal Cell Carcinoma.

Upload

This paper is made freely available by the publisher.

Igor Puzanov

ORCID

, Mohammed M. Milhem, Milhem Mm, Andtbacka Rh, David Minor, Omid Hamid, Ai Li, Lisa Chen, Michael Chastain, Kevin S. Gorski, Gorski Ks, Abraham Anderson, Jeffrey Chou, Kaufman Hl, Howard L. Kaufman and 1 other authors

Talimogene Laherparepvec in Combination With Ipilimumab in Previously Untreated, Unresectable Stage IIIB-IV Melanoma

Download from doi.org

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Johnson Db, J. Roszik, Shoushtari An, Z. Eroglu, Balko Jm, C. Higham, I. Puzanov

ORCID

, Patel Sp, Sosman Ja, Woodman Se

Comparative analysis of the GNAQ, GNA11, SF3B1, and EIF1AX driver mutations in melanoma and across the cancer spectrum.

Upload

This paper is available in a repository.

Robert H. I. Andtbacka, Andtbacka Rh, Merrick Ross, Igor Puzanov

ORCID

, Mohammed Milhem, Jonathan S. Zager, Frances Collichio, Keith A. Delman, Delman Ka, Thomas Amatruda, Zager Js, Lee Cranmer, Eddy Hsueh, Lisa Chen, Mark Shilkrut and 2 other authors

Patterns of Clinical Response with Talimogene Laherparepvec (T-VEC) in Patients with Melanoma Treated in the OPTiM Phase III Clinical Trial

Download from doi.org

This paper is made freely available by the publisher.

Amanda Shreders, Richard Joseph, Chengwei Peng, Fei Ye, Shilin Zhao, Igor Puzanov

ORCID

, Sosman Ja, Jeffrey A. Sosman, Johnson Db, Douglas B. Johnson

Prolonged Benefit from Ipilimumab Correlates with Improved Outcomes from Subsequent Pembrolizumab

Download from cancerimmunolres.aacrjournals.org

This paper is made freely available by the publisher.

Greenplate Ar, Allison R. Greenplate, Michael R. Savona, Jeffrey A. Sosman, Johnson Db, Douglas B. Johnson, Mikael Roussel

ORCID

, Savona Mr, Sosman Ja, Igor Puzanov

ORCID

, P. Brent Ferrell, Ferrell Pb, Jonathan M. Irish

ORCID

, Irish Jm

Myelodysplastic Syndrome Revealed by Systems Immunology in a Melanoma Patient Undergoing Anti-PD-1 Therapy

Download from cancerimmunolres.aacrjournals.org

This paper is available in a repository.

Naomi B. Haas, Haas Nb, Judith Manola, Wong Yn, Robert G. Uzzo, Uzzo Rg, Keith T. Flaherty, Flaherty Kt, Christopher G. Wood, Wood Cg, Christopher Kane, Michael Jewett, Janice P. Dutcher, Michael B. Atkins, Dutcher Jp and 20 other authors

Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial

Download from europepmc.org

Distributing this paper is prohibited by the publisher

Johnson Db, Sullivan Rj, Ryan J. Sullivan, Ott Pa, Patrick A. Ott, Carlino Ms, Khushalani Ni, Fei Ye, Tejaswi Mudigonda, Kristen Spencer, Igor Puzanov

ORCID

, Jeffrey A. Sosman, Douglas B. Johnson, Matteo S. Carlino

ORCID

, Nikhil I. Khushalani and 19 other authors

Ipilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune Disorders

Upload

This paper is made freely available by the publisher.

Douglas B. Johnson, Johnson Db, Monica V. Estrada

ORCID

, Estrada Mv, Roberto Salgado, Violeta Sanchez, Deon B. Doxie, Doxie Db, Susan R. Opalenik, Anna E. Vilgelm, Opalenik Sr, Vilgelm Ae, Emily Feld, Adam S. Johnson, Johnson As and 20 other authors

Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy

Download from www.nature.com

This paper is made freely available by the publisher.

Georgina V. Long, Jeffrey S. Weber, Long Gv, Weber Js, Jeffrey R. Infante, Infante Jr, Kevin B. Kim, Adil Daud, Rene Gonzalez, Kim Kb, Jeffrey A. Sosman, Omid Hamid, Lynn Schuchter, Sosman Ja, Jonathan Cebon and 19 other authors

Overall Survival and Durable Responses in Patients With BRAF V600-Mutant Metastatic Melanoma Receiving Dabrafenib Combined With Trametinib

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

Armstrong Aj, Stadler Wm, Andrew J. Armstrong, Susan Halabi

ORCID

, Tim Eisen, Samuel Broderick, Walter M. Stadler, Robert J. Jones, Jones Rj, Jorge A. Garcia, Garcia Ja, Vaishampayan Un, Ulka N. Vaishampayan, Joel Picus, Robert E. Hawkins and 18 other authors

Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Igor Puzanov

ORCID

Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015.

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Gilbert Bader, Igor Puzanov

ORCID

, Kanishka Chakraborty

Thyroid nodule: not as clear-cut as it seems

Upload

Distributing this paper is prohibited by the publisher

2015 Kevin J. Harrington

ORCID

, Harrington Kj, Igor Puzanov

ORCID

, J. Randolph Hecht, Hecht Jr, Hodi Fs, F. Stephen Hodi, Zsolt Szabo, Swami Murugappan, Kaufman Hl, Howard L. Kaufman

Clinical development of talimogene laherparepvec (T-VEC): a modified herpes simplex virus type-1–derived oncolytic immunotherapy

Upload

This paper is made freely available by the publisher.

Georgina V. Long, Long Gv, Reinhard Dummer, Antoni Ribas, Igor Puzanov

ORCID

, Olivier Michielin, Ari VanderWalde, Robert Hi Andtbacka, Andtbacka Rh, Jonathan Cebon, Eugenio Fernandez, Josep Malvehy, Anthony J. Olszanski, Olszanski Aj, Thomas F. Gajewski and 11 other authors

A Phase I/III, multicenter, open-label trial of talimogene laherparepvec (T-VEC) in combination with pembrolizumab for the treatment of unresected, stage IIIb-IV melanoma (MASTERKEY-265)

Download from dx.doi.org

This paper is made freely available by the publisher.

Choueiri Tk, Michael B. Atkins, Atkins Mb, Shilpa Gupta, Toni K. Choueiri, McDermott Df, David F. McDermott, Igor Puzanov

ORCID

, Jamal Tarazi, Stephen Keefe, Brad Rosbrook, Debasis Chakrabarti, Plimack Er, Elizabeth R. Plimack

Phase Ib dose-finding study of axitinib plus pembrolizumab in treatment-naïve patients with advanced renal cell carcinoma

Download from link.springer.com

Missing publications? Search for publications with a matching author name.